Arab Press

بالشعب و للشعب
Thursday, Dec 04, 2025

Bill Gates and Tony Blair on the urgent need to end vaccine apartheid

Bill Gates and Tony Blair on the urgent need to end vaccine apartheid

Huge parts of the world are getting left behind, remaining unvaccinated - here, global thought leaders say we need to step up fast

Every day, when Mandy Malambo goes to work at the hospital where she is a nurse in Zambia, she runs through the same worst case scenario in her mind. “You think, what if today is the day I contract Covid?” Malambo is lucky, she has had one dose of the vaccine, but most of her colleagues are unvaccinated. In Zambia just 1.1 per cent of the population have had both jabs, and Covid cases are rising. It is a stark contrast to the UK, where more than half of the population have had two doses of the vaccine and we are tentatively starting to think about a post-pandemic future. Focusing on the positive is tempting but look beyond the UK and the pandemic is still raging. Last week, there were four million new cases of Covid across the world, and many of them in are countries where people have not been vaccinated. Nearly 70 per cent of people worldwide are yet to receive a single dose of the vaccine and only 1.2 per cent of people in low-income countries have received at least one dose.

Bill Gates, who is working through the foundation he co-chairs to address this vaccine apartheid, says urgent action is needed. “As long as there are large pockets of unvaccinated people — either at home or abroad — we risk continued surges and additional variants that could put us all at risk. The only way to get out of the cycle of recovery and relapse is to make vaccines available to everyone as quickly as possible.” In other words, if we don’t look at Covid globally, it is more likely to mutate and be less responsive to vaccines — so we face a battle of variants versus vaccines. Meanwhile, the IMF and the World Bank have warned that if the vaccine is not shared out more equally, international trade and travel will not get back to normal and the global economy will continue to suffer.

The WHO is aiming for 10 per cent of every country’s population to be vaccinated by the end of September and estimates at least 60 to 70 per cent of the world needs to be inoculated to reach “global immunity” — but how realistic is this? It is not that there is a shortage of vaccines — in the UK, for example, we have more than our population needs several times over. It is more that they are not being shared equally or fast enough, compounded by the fact that there were early problems with supply which affected Africa — leading to calls to share patents and enable Africa to manufacture the vaccine.

“We need more high-income countries to share vaccine doses faster,” says Gates. “And more funding to buy doses for lower-income countries for 2022 and beyond. As the volume of doses increases toward the end of the year, we need to support countries so they are ready to receive and administer them as quickly as possible.” The race to provide booster shots in the West, with Germany and France already planning them, isn’t helping, putting pressure on supplies the developing world. The WHO is calling for a global moratorium on boosters until enough people across the world have had two doses of the vaccine.

"As long as there are large pockets of unvaccinated people — either at home or abroad — we risk continued surges and additional variants that could put us all at risk. The only way to get out of the cycle of recovery and relapse is to make vaccines available to everyone as quickly as possible"


Covax, a UN-backed alliance of international health bodies and non-profits, was set up last year to try to prevent the problem we now face and ensure that poor countries received vaccines as quickly as rich ones. However it has struggled, with one of the problems being that richer countries are paying premiums to get vaccines. In January, Covax promised to deliver 100 million doses by the end of March but that figure currently stands at less than 50 million.

Strive Masiyiwa, the African Union Special Envoy to the African Vaccine Acquisition Task Team, has criticised Covax and says the solution is to let African countries manufacture the vaccine themselves, licensing production in Africa and supporting areas to get the right equipment to make and distribute the vaccine rather than doing piecemeal contract deals. “The fact is, it’s not about sharing. It’s about allowing us access to production. Loosen contracts so that the supply capacity can be released to other nations; that is all we ask.”

There was a promise made at the G7 to share 870 million additional doses but this is “a token trickle”, says Robert Yates, Head of the Centre on Global Health Security at Chatham House. “The performance of the G7 has been pathetic,” Yates continues. “There was nothing about funding or the tech transfers we need around the world to make it easier to roll-out the vaccine. This is realpolitik — politicians are putting the lives of their own populations first, which is justified for high risk groups, but now we risk vaccine apartheid. It is to the WHO’s credit that they have called the UK and the US out on this, as we give them funding. But it is inefficient and immoral that we are thinking about vaccinating 16 and 17-year-olds before health workers in other countries.” Yates adds: “There is not sufficient public outrage, people are not demanding leaders roll-out the vaccine around the world.”

There are fears that we will see a repeat of what happened with HIV and Aids, where it took a decade to make drugs to combat the disease widely available all over the world, or swine flu, where rich nations bought the vaccine leaving poorer ones suffering. “This rampant nationalism doesn’t augur well for other existential threats to humanity,” says Yates. “Where does it lead us on issues like climate change where we need to collaborate on a global scale?”

"This rampant nationalism doesn’t augur well for other existential threats to humanity. Where does it lead us on issues like climate change where we need to collaborate on a global scale"


Will Hall, Global Policy and Advocacy Manager at The Wellcome Trust breaks down what is needed into three areas: “Bold leadership, dose sharing to go much faster and to Covax while trying to build supplies, and funding.” A partnership has been set up to get the vaccine to those who need it, called the Access to Covid Tools Accelerator, but it has a funding gap of $16.6 billion this year.

Leadership too has been “lacking”, says Tony Blair , who has set out how we could vaccinate the most vulnerable strategically, through his Institute and the Global Health Security Consortium. “The scientific and medical progress which we’ve seen in response to the pandemic has not, sadly, been matched by a similar degree of leadership in the international community, though that may be changing,” he says.

But dispatching vaccines is not enough. “We need to maximise the supply; co-ordinate supply to countries which have the ability to use them; and strategically vaccinate key populations to minimise mortality and transmission and maintain vital services. Countries need our support to grow their capacity to deliver vaccines, so they are able to get to them into arms as efficiently as possible.”

Getting the vaccine to the people it needs to go to is a huge challenge. Pfizer, for example, must be kept at low temperatures and some African officials worry that their electrical grids could be overwhelmed by having that many freezers. In Chad, there is only the capacity to distribute Pfizer in major cities.

Labour MPs including Emily Thornberry sent our Government a 10-point plan to increase production and distribution in May but it has yet to see action. “It’s a catastrophic failure of global leadership,” says Thornberry. “We’re trapped in a cycle. There are billions of unvaccinated people, so new variants spread throughout the world, all the attention switches back to America and Europe, nothing gets done about the poorer countries, and the cycle begins again. The only way to break it is a massive increase in production and distribution.”

There is a another opportunity this year for leaders make commitments on the vaccine, at the G20 in October. “Let’s hope they pick up the ball where the G7 dropped it,” says Yates. “It’s to our shame that we aren’t taking vaccinating the world more seriously.” Malambo is hopeful that the comments of figures like Gates means that the world is starting to listen. “Now we need to spread the word about the benefits of the vaccine to everyone.”

Newsletter

Related Articles

Arab Press
0:00
0:00
Close
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
OPEC+ Unveils New Capacity-Based System to Anchor Future Oil Output Levels
Hong Kong Residents Mourn Victims as 1,500 People Relocated After Devastating Tower Fire
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
Saudi Crown Prince Meets Trump in Washington to Deepen Defence, AI and Nuclear Ties
×